#
Benzefoam Ultra
  • Professionals
  • FDA PI

Benzefoam Ultra

Generic name:benzoyl peroxide
Dosage form: aerosol, foam
Drug class:Topical acne agents

Medically reviewed by Drugs.com. Last updated on May 23, 2022.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Benzefoam Ultra Description

Each gram of BenzEFoamUltraTM Short Contact Foam contains 9.8% benzoyl peroxide in an aqueous based emollient foam vehicle containing BHT, C12-15 alkyl benzoate, cetearyl alcohol, citric acid, dimethicone, disodium EDTA, emulsifying wax, glycerin, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate, steareth10. Also contains: Propellant HFA-134a (1,1,1,2-tetrafluoroethane).

Benzoyl peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl peroxide (C14H10O4) is represented by the following structure:

Benzefoam Ultra - Clinical Pharmacology

The exact method of action of benzoyl peroxide in acne vulgaris is not known. Benzoyl peroxide is an antibacterial agent with demonstrated activity against Propionibacterium acnes. This action, combined with the mild keratolytic effect of benzoyl peroxide, is believed to be responsible for its usefulness in acne. Benzoyl peroxide is absorbed by the skin where it is metabolized to benzoic acid and excreted as benzoate in the urine.

Indications and Usage for Benzefoam Ultra

BenzEFoamUltraTM Short Contact Foam is indicated for use in the topical treatment of mild to moderate acne vulgaris.

Contraindications

BenzEFoamUltraTM Short Contact Foam should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the prod...